Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension

Pulmonary arterial hypertension is a progressive disease that can lead to right-sided ventricular failure and premature death. Tailoring therapy to individual patient’s needs, along with regular risk assessment, is integral for optimal outcomes in patients with pulmonary arterial hypertension. Resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahay, Sandeep, Rahaghi, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052464/
https://www.ncbi.nlm.nih.gov/pubmed/32166019
http://dx.doi.org/10.1177/2045894020910098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052464/
https://www.ncbi.nlm.nih.gov/pubmed/32166019
http://dx.doi.org/10.1177/2045894020910098

Ejemplares similares